Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Review Highlights Nipah Virus Placental Crossing in Animal Models

November 17, 2026 Dr. Michael Lee – Health Editor Health

Nipah virus breaches the placental barrier and infects fetal organs in animal models, though confirmed vertical transmission in human clinical cases remains unestablished, bioengineer.org reported in a comprehensive scientific review published in Frontiers in Public Health.

Key Clinical Takeaways:

  • The World Health Organization classifies the enveloped RNA henipavirus as an urgent priority pathogen due to case fatality rates between 40 percent and 90 percent.
  • Experimental inoculations in pregnant cats demonstrate that the virus reaches reproductive tissues, amniotic fluid, and fetal organs, inducing pulmonary vasculitis and placentitis.
  • A single well-documented survivor in Faridpur, Bangladesh, who contracted acute encephalitis from raw date palm sap in January 2020, later delivered a healthy infant carrying maternal immunoglobulin G antibodies but no viral RNA.

Viral Genome Encodes Proteins That Drive Systemic Tropism

Spanning approximately 18.2 kilobases, the viral genome encodes six structural proteins that drive widespread systemic tropism. Infection initiates when the viral attachment glycoprotein binds host ephrin-B2 or ephrin-B3 cell surface receptors, triggering membrane entry into target cells according to Zhan, Deji, Zhong, and Qing (2026) in Frontiers in Public Health.

Because these receptors are extensively expressed across arterial endothelial cells, vascular smooth muscle cells, neurons, and respiratory epithelium, the virus disseminates into vascular endothelial cells after initial respiratory replication.

Bats of the Pteropodidae family—specifically Pteropus medius—act as the primary zoonotic source, transmitting the infection when individuals ingest raw date palm sap or produce tainted by fruits. Human-to-human transmission subsequently proceeds through direct contact with contaminated bodily fluids or respiratory droplets during outbreaks concentrated primarily in Bangladesh and India.

Gestational Physiology and Animal Models

Pregnancy alters the clinical trajectory of severe viral infections through stage-specific immunological adaptations. The precise moment the Nipah virus develops systemic viremia aligns exactly with the lessening of maternal cell-mediated antiviral protections occurring throughout the tolerogenic mid-gestational phase.

Direct experimental evidence confirms the biological capacity of the pathogen to infect reproductive structures. Post-mortem examinations of pregnant cats given subcutaneous inoculations showed elevated levels of viral genetic material inside the placenta, uterine horns, ovaries, and amniotic fluid, with infectious viral titers measured at 126,000 TCID50 per milliliter.

Critical Care Manages Patients Without Approved Therapeutics

Clinical management focuses on rigorous critical care, strict infection control, and multidisciplinary coordination because no approved vaccines or targeted antiviral therapeutics currently exist. Maternal stabilization represents the overriding priority, directing aggressive oxygen supplementation, protective lung mechanical ventilation, osmotic therapy for intracranial hypertension, and anticonvulsant seizure control.

Pharmacological interventions remain constrained by scarce safety data and significant fetal risk. Preclinical animal trials show that favipiravir causes recognized teratogenic harm, ribavirin acts as a strong teratogen that is barred during all of pregnancy, and chloroquine has shown zero therapeutic success in live subjects.

On the other hand, giving the nucleotide analog remdesivir 24 hours after exposure resulted in complete 100 percent survival rates during testing with African green monkeys. At the same time, because of its bulky immunoglobulin G1 molecular framework, m102.4—a fully human monoclonal antibody directed against the viral G glycoprotein—shows very little transfer across the placenta during the first and second trimesters.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • New Study Suggests HPV Vaccine May Help Prevent Premature Birth
  • Management of Takotsubo Syndrome in a Patient With Pneumonia and Suspected COPD

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service